DEA Opens New Schedule III Registration Portal for Medical Cannabis Businesses
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and analytical laboratories seeking to operate under Schedule III. The move brings qualifying medical cannabis businesses into a federal controlled-substances framework while potentially offering major tax advantages by ending the Section 280E deduction ban for those businesses. Schedule III Is Coming […]